Our mission is to improve our understanding of FTLD-tau pathobiology, with a diverse team of scientists, students, and collaborators.
Vision
We envision that our work to understand the fundamental biology of tau metabolism will impact the broader field of neurodegeneration research and launch subsequent investigations into tau toxicity and pathobiology. Ultimately, we hope that our findings will translate into uplifting the lives of our patients.
Values
We honor our core values and reflect them in our work.
DIVERSITY, INCLUSION, & EQUITY
Uplifting diversity, ensuring justice and fairness, and welcoming all.
WOMEN IN NEUROSCIENCE
Recognizing and empowering women in science.
OPEN DATA SHARING & COLLABORATION
Enabling rapid data sharing and openness.
MULTIDISCIPLINARY WORK
Bringing different perspectives to the table.
TRANSLATIONAL RESEARCH
Keeping our patients at the forefront of everything we do.
Our Sponsors
U54 Center without Walls for Mechanisms of Neurodegeneration in Frontotemporal Dementia
“The goal of the Frontotemporal Dementia (FTD) Centers Without Walls (CWOW) is to improve our understanding of the mechanisms underlying neurodegeneration in FTD through multi-disciplinary, team-based science to address a specific challenge or challenges in the field that could not be achieved through individual research projects.” As seen on NIH website
We are very grateful to be able to perform this tau research. Thank you to our funders:
- The National Institutes of Health (NIH) is the nation’s medical research agency. The NIH is making strides towards important discoveries by supporting scientific studies that improve health and save lives.
- The National Institute on Aging (NIA) pursues the scientific effort to understand the nature of aging and to extend the healthy years of life. The NIA is focused on supporting and conducting Alzheimer's disease research.
- The National Institute of Neurological Disorders and Stroke (NINDS) seeks the fundamental knowledge about the brain and nervous system and in turn, to reduce the burden of neurological disease for all people.
